nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLCO2B1—Erlotinib—lung cancer	0.461	1	CbGbCtD
Latanoprost—Dinoprost Tromethamine—HPGDS—lung cancer	0.00621	0.741	CrCbGaD
Latanoprost—PTGFR—respiratory system—lung cancer	0.00367	0.188	CbGeAlD
Latanoprost—SLCO2B1—mammary gland—lung cancer	0.00304	0.155	CbGeAlD
Latanoprost—PTGFR—bronchus—lung cancer	0.00302	0.154	CbGeAlD
Latanoprost—PTGFR—trachea—lung cancer	0.00272	0.139	CbGeAlD
Latanoprost—Tafluprost—PTGS2—lung cancer	0.00217	0.259	CrCbGaD
Latanoprost—SLCO2B1—respiratory system—lung cancer	0.00203	0.103	CbGeAlD
Latanoprost—PTGFR—lung—lung cancer	0.00195	0.0997	CbGeAlD
Latanoprost—Dyspnoea—Pemetrexed—lung cancer	0.00151	0.00385	CcSEcCtD
Latanoprost—Lacrimation increased—Docetaxel—lung cancer	0.00151	0.00385	CcSEcCtD
Latanoprost—Dyspnoea—Gefitinib—lung cancer	0.0015	0.00383	CcSEcCtD
Latanoprost—Angina pectoris—Vinorelbine—lung cancer	0.00149	0.0038	CcSEcCtD
Latanoprost—Pain—Pemetrexed—lung cancer	0.00145	0.00369	CcSEcCtD
Latanoprost—Pain—Gefitinib—lung cancer	0.00144	0.00367	CcSEcCtD
Latanoprost—Inflammation—Docetaxel—lung cancer	0.00143	0.00365	CcSEcCtD
Latanoprost—Chest pain—Teniposide—lung cancer	0.00143	0.00365	CcSEcCtD
Latanoprost—Connective tissue disorder—Erlotinib—lung cancer	0.00139	0.00355	CcSEcCtD
Latanoprost—Oedema—Teniposide—lung cancer	0.00137	0.0035	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—lung cancer	0.00135	0.00345	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—lung cancer	0.00134	0.00341	CcSEcCtD
Latanoprost—PTGFR—lymph node—lung cancer	0.00133	0.0682	CbGeAlD
Latanoprost—Eye pain—Paclitaxel—lung cancer	0.00132	0.00336	CcSEcCtD
Latanoprost—Mediastinal disorder—Topotecan—lung cancer	0.00129	0.00329	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Gemcitabine—lung cancer	0.00128	0.00327	CcSEcCtD
Latanoprost—Mediastinal disorder—Erlotinib—lung cancer	0.00128	0.00325	CcSEcCtD
Latanoprost—Erythema—Erlotinib—lung cancer	0.00123	0.00314	CcSEcCtD
Latanoprost—Angina pectoris—Irinotecan—lung cancer	0.00123	0.00313	CcSEcCtD
Latanoprost—Dizziness—Crizotinib—lung cancer	0.00123	0.00313	CcSEcCtD
Latanoprost—Dyspnoea—Teniposide—lung cancer	0.00122	0.00312	CcSEcCtD
Latanoprost—Back pain—Topotecan—lung cancer	0.00121	0.00307	CcSEcCtD
Latanoprost—Connective tissue disorder—Vinorelbine—lung cancer	0.0012	0.00307	CcSEcCtD
Latanoprost—Pruritus—Pemetrexed—lung cancer	0.0012	0.00306	CcSEcCtD
Latanoprost—Back pain—Erlotinib—lung cancer	0.00119	0.00304	CcSEcCtD
Latanoprost—Pruritus—Gefitinib—lung cancer	0.00119	0.00304	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Irinotecan—lung cancer	0.00117	0.00299	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—lung cancer	0.00117	0.00299	CcSEcCtD
Latanoprost—Rash—Crizotinib—lung cancer	0.00117	0.00298	CcSEcCtD
Latanoprost—Dermatitis—Crizotinib—lung cancer	0.00117	0.00298	CcSEcCtD
Latanoprost—Dizziness—Pemetrexed—lung cancer	0.00112	0.00286	CcSEcCtD
Latanoprost—Mediastinal disorder—Vinorelbine—lung cancer	0.0011	0.00281	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Etoposide—lung cancer	0.00109	0.00279	CcSEcCtD
Latanoprost—Discomfort—Vinblastine—lung cancer	0.00108	0.00275	CcSEcCtD
Latanoprost—SLCO2B1—lung—lung cancer	0.00108	0.055	CbGeAlD
Latanoprost—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.00107	0.00273	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—lung cancer	0.00107	0.00273	CcSEcCtD
Latanoprost—Rash—Pemetrexed—lung cancer	0.00107	0.00272	CcSEcCtD
Latanoprost—Dermatitis—Pemetrexed—lung cancer	0.00107	0.00272	CcSEcCtD
Latanoprost—Erythema—Vinorelbine—lung cancer	0.00107	0.00272	CcSEcCtD
Latanoprost—Rash—Gefitinib—lung cancer	0.00106	0.00271	CcSEcCtD
Latanoprost—Arthralgia—Topotecan—lung cancer	0.00106	0.00271	CcSEcCtD
Latanoprost—Chest pain—Topotecan—lung cancer	0.00106	0.00271	CcSEcCtD
Latanoprost—Dermatitis—Gefitinib—lung cancer	0.00106	0.0027	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.00105	0.00269	CcSEcCtD
Latanoprost—Arthralgia—Erlotinib—lung cancer	0.00105	0.00268	CcSEcCtD
Latanoprost—Chest pain—Erlotinib—lung cancer	0.00105	0.00268	CcSEcCtD
Latanoprost—Discomfort—Topotecan—lung cancer	0.00105	0.00267	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.00104	0.00266	CcSEcCtD
Latanoprost—Inflammation—Methotrexate—lung cancer	0.00103	0.00263	CcSEcCtD
Latanoprost—Back pain—Vinorelbine—lung cancer	0.00103	0.00263	CcSEcCtD
Latanoprost—Oedema—Erlotinib—lung cancer	0.00101	0.00257	CcSEcCtD
Latanoprost—Nervous system disorder—Topotecan—lung cancer	0.000998	0.00254	CcSEcCtD
Latanoprost—Conjunctivitis—Cisplatin—lung cancer	0.000994	0.00253	CcSEcCtD
Latanoprost—Connective tissue disorder—Irinotecan—lung cancer	0.000993	0.00253	CcSEcCtD
Latanoprost—Bronchitis—Paclitaxel—lung cancer	0.00099	0.00252	CcSEcCtD
Latanoprost—Skin disorder—Topotecan—lung cancer	0.000989	0.00252	CcSEcCtD
Latanoprost—Nervous system disorder—Erlotinib—lung cancer	0.000988	0.00252	CcSEcCtD
Latanoprost—Skin disorder—Erlotinib—lung cancer	0.000978	0.00249	CcSEcCtD
Latanoprost—Pruritus—Teniposide—lung cancer	0.000972	0.00248	CcSEcCtD
Latanoprost—Connective tissue disorder—Gemcitabine—lung cancer	0.000968	0.00247	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Paclitaxel—lung cancer	0.000957	0.00244	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—lung cancer	0.000942	0.0024	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Topotecan—lung cancer	0.000927	0.00236	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000917	0.00234	CcSEcCtD
Latanoprost—Mediastinal disorder—Irinotecan—lung cancer	0.000911	0.00232	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.000909	0.00232	CcSEcCtD
Latanoprost—Chest pain—Vinorelbine—lung cancer	0.000908	0.00231	CcSEcCtD
Latanoprost—Arthralgia—Vinorelbine—lung cancer	0.000908	0.00231	CcSEcCtD
Latanoprost—Dyspnoea—Topotecan—lung cancer	0.000907	0.00231	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000902	0.0023	CcSEcCtD
Latanoprost—Connective tissue disorder—Cisplatin—lung cancer	0.000902	0.0023	CcSEcCtD
Latanoprost—Dyspnoea—Erlotinib—lung cancer	0.000898	0.00229	CcSEcCtD
Latanoprost—Discomfort—Vinorelbine—lung cancer	0.000897	0.00229	CcSEcCtD
Latanoprost—Pain—Vinblastine—lung cancer	0.000896	0.00228	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—lung cancer	0.000895	0.00228	CcSEcCtD
Latanoprost—Urinary tract infection—Paclitaxel—lung cancer	0.000893	0.00227	CcSEcCtD
Latanoprost—Conjunctivitis—Paclitaxel—lung cancer	0.000893	0.00227	CcSEcCtD
Latanoprost—Mediastinal disorder—Gemcitabine—lung cancer	0.000887	0.00226	CcSEcCtD
Latanoprost—Pain—Topotecan—lung cancer	0.00087	0.00222	CcSEcCtD
Latanoprost—Rash—Teniposide—lung cancer	0.000866	0.00221	CcSEcCtD
Latanoprost—Dermatitis—Teniposide—lung cancer	0.000865	0.0022	CcSEcCtD
Latanoprost—Pain—Erlotinib—lung cancer	0.000861	0.00219	CcSEcCtD
Latanoprost—Headache—Teniposide—lung cancer	0.00086	0.00219	CcSEcCtD
Latanoprost—Erythema—Gemcitabine—lung cancer	0.000857	0.00218	CcSEcCtD
Latanoprost—Nervous system disorder—Vinorelbine—lung cancer	0.000854	0.00218	CcSEcCtD
Latanoprost—Back pain—Irinotecan—lung cancer	0.000851	0.00217	CcSEcCtD
Latanoprost—Angina pectoris—Docetaxel—lung cancer	0.00085	0.00217	CcSEcCtD
Latanoprost—Skin disorder—Vinorelbine—lung cancer	0.000846	0.00215	CcSEcCtD
Latanoprost—Back pain—Gemcitabine—lung cancer	0.000829	0.00211	CcSEcCtD
Latanoprost—Mediastinal disorder—Cisplatin—lung cancer	0.000827	0.00211	CcSEcCtD
Latanoprost—Connective tissue disorder—Paclitaxel—lung cancer	0.00081	0.00206	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—lung cancer	0.000802	0.00204	CcSEcCtD
Latanoprost—Erythema—Cisplatin—lung cancer	0.000799	0.00204	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000793	0.00202	CcSEcCtD
Latanoprost—Dyspnoea—Vinorelbine—lung cancer	0.000776	0.00198	CcSEcCtD
Latanoprost—Mediastinal disorder—Etoposide—lung cancer	0.000758	0.00193	CcSEcCtD
Latanoprost—Conjunctivitis—Docetaxel—lung cancer	0.000757	0.00193	CcSEcCtD
Latanoprost—Vision blurred—Cisplatin—lung cancer	0.000753	0.00192	CcSEcCtD
Latanoprost—Pain—Vinorelbine—lung cancer	0.000745	0.0019	CcSEcCtD
Latanoprost—Mediastinal disorder—Paclitaxel—lung cancer	0.000743	0.00189	CcSEcCtD
Latanoprost—Discomfort—Irinotecan—lung cancer	0.00074	0.00189	CcSEcCtD
Latanoprost—SLCO2B1—lymph node—lung cancer	0.000736	0.0376	CbGeAlD
Latanoprost—Arthralgia—Gemcitabine—lung cancer	0.00073	0.00186	CcSEcCtD
Latanoprost—Chest pain—Gemcitabine—lung cancer	0.00073	0.00186	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000725	0.00185	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—lung cancer	0.000721	0.00184	CcSEcCtD
Latanoprost—Discomfort—Gemcitabine—lung cancer	0.000721	0.00184	CcSEcCtD
Latanoprost—Pruritus—Topotecan—lung cancer	0.00072	0.00183	CcSEcCtD
Latanoprost—Oedema—Irinotecan—lung cancer	0.000718	0.00183	CcSEcCtD
Latanoprost—Erythema—Paclitaxel—lung cancer	0.000718	0.00183	CcSEcCtD
Latanoprost—Pruritus—Erlotinib—lung cancer	0.000712	0.00182	CcSEcCtD
Latanoprost—Back pain—Etoposide—lung cancer	0.000708	0.0018	CcSEcCtD
Latanoprost—Nervous system disorder—Irinotecan—lung cancer	0.000704	0.00179	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—lung cancer	0.000701	0.00179	CcSEcCtD
Latanoprost—Oedema—Gemcitabine—lung cancer	0.000699	0.00178	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—lung cancer	0.000698	0.00178	CcSEcCtD
Latanoprost—Back pain—Paclitaxel—lung cancer	0.000694	0.00177	CcSEcCtD
Latanoprost—Dizziness—Vinblastine—lung cancer	0.000693	0.00177	CcSEcCtD
Latanoprost—Connective tissue disorder—Docetaxel—lung cancer	0.000687	0.00175	CcSEcCtD
Latanoprost—Nervous system disorder—Gemcitabine—lung cancer	0.000686	0.00175	CcSEcCtD
Latanoprost—Skin disorder—Gemcitabine—lung cancer	0.000679	0.00173	CcSEcCtD
Latanoprost—Vision blurred—Paclitaxel—lung cancer	0.000676	0.00172	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000675	0.00172	CcSEcCtD
Latanoprost—Dizziness—Topotecan—lung cancer	0.000673	0.00171	CcSEcCtD
Latanoprost—Discomfort—Cisplatin—lung cancer	0.000672	0.00171	CcSEcCtD
Latanoprost—Dizziness—Erlotinib—lung cancer	0.000666	0.0017	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000663	0.0056	CbGpPWpGaD
Latanoprost—Headache—Vinblastine—lung cancer	0.000656	0.00167	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000656	0.00167	CcSEcCtD
Latanoprost—Oedema—Cisplatin—lung cancer	0.000652	0.00166	CcSEcCtD
Latanoprost—Rash—Topotecan—lung cancer	0.000642	0.00164	CcSEcCtD
Latanoprost—Dermatitis—Topotecan—lung cancer	0.000641	0.00163	CcSEcCtD
Latanoprost—Dyspnoea—Irinotecan—lung cancer	0.00064	0.00163	CcSEcCtD
Latanoprost—Nervous system disorder—Cisplatin—lung cancer	0.000639	0.00163	CcSEcCtD
Latanoprost—Headache—Topotecan—lung cancer	0.000638	0.00162	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000637	0.00162	CcSEcCtD
Latanoprost—Rash—Erlotinib—lung cancer	0.000635	0.00162	CcSEcCtD
Latanoprost—Dermatitis—Erlotinib—lung cancer	0.000634	0.00162	CcSEcCtD
Latanoprost—Skin disorder—Cisplatin—lung cancer	0.000633	0.00161	CcSEcCtD
Latanoprost—Headache—Erlotinib—lung cancer	0.000631	0.00161	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—lung cancer	0.00063	0.00161	CcSEcCtD
Latanoprost—Mediastinal disorder—Docetaxel—lung cancer	0.00063	0.0016	CcSEcCtD
Latanoprost—Asthma—Methotrexate—lung cancer	0.000629	0.0016	CcSEcCtD
Latanoprost—Dyspnoea—Gemcitabine—lung cancer	0.000624	0.00159	CcSEcCtD
Latanoprost—Chest pain—Etoposide—lung cancer	0.000623	0.00159	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000619	0.00158	CcSEcCtD
Latanoprost—Pruritus—Vinorelbine—lung cancer	0.000616	0.00157	CcSEcCtD
Latanoprost—Discomfort—Etoposide—lung cancer	0.000616	0.00157	CcSEcCtD
Latanoprost—Pain—Irinotecan—lung cancer	0.000614	0.00156	CcSEcCtD
Latanoprost—Arthralgia—Paclitaxel—lung cancer	0.000611	0.00156	CcSEcCtD
Latanoprost—Chest pain—Paclitaxel—lung cancer	0.000611	0.00156	CcSEcCtD
Latanoprost—Erythema—Docetaxel—lung cancer	0.000608	0.00155	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000607	0.00155	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—AVP—lung cancer	0.000606	0.00513	CbGpPWpGaD
Latanoprost—Discomfort—Paclitaxel—lung cancer	0.000604	0.00154	CcSEcCtD
Latanoprost—Pain—Gemcitabine—lung cancer	0.000598	0.00152	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000594	0.00151	CcSEcCtD
Latanoprost—Back pain—Docetaxel—lung cancer	0.000588	0.0015	CcSEcCtD
Latanoprost—Oedema—Paclitaxel—lung cancer	0.000586	0.00149	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—lung cancer	0.000585	0.00149	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000584	0.00494	CbGpPWpGaD
Latanoprost—Dyspnoea—Cisplatin—lung cancer	0.000581	0.00148	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—lung cancer	0.00058	0.00148	CcSEcCtD
Latanoprost—Dizziness—Vinorelbine—lung cancer	0.000576	0.00147	CcSEcCtD
Latanoprost—Nervous system disorder—Paclitaxel—lung cancer	0.000574	0.00146	CcSEcCtD
Latanoprost—Skin disorder—Paclitaxel—lung cancer	0.000569	0.00145	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000568	0.00145	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—OXTR—lung cancer	0.000564	0.00477	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—GRP—lung cancer	0.000564	0.00477	CbGpPWpGaD
Latanoprost—Pain—Cisplatin—lung cancer	0.000558	0.00142	CcSEcCtD
Latanoprost—Rash—Vinorelbine—lung cancer	0.000549	0.0014	CcSEcCtD
Latanoprost—Dermatitis—Vinorelbine—lung cancer	0.000548	0.0014	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000546	0.00462	CbGpPWpGaD
Latanoprost—Headache—Vinorelbine—lung cancer	0.000545	0.00139	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—lung cancer	0.000545	0.00139	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000545	0.00461	CbGpPWpGaD
Latanoprost—Asthma—Doxorubicin—lung cancer	0.000545	0.00139	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000542	0.00458	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000534	0.00136	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—lung cancer	0.000533	0.00136	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—lung cancer	0.000531	0.00135	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—GNG11—lung cancer	0.000528	0.00446	CbGpPWpGaD
Latanoprost—Bronchitis—Doxorubicin—lung cancer	0.000524	0.00133	CcSEcCtD
Latanoprost—Dyspnoea—Paclitaxel—lung cancer	0.000522	0.00133	CcSEcCtD
Latanoprost—Arthralgia—Docetaxel—lung cancer	0.000518	0.00132	CcSEcCtD
Latanoprost—Chest pain—Docetaxel—lung cancer	0.000518	0.00132	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000516	0.00437	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000514	0.00131	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—GRIK3—lung cancer	0.000513	0.00434	CbGpPWpGaD
Latanoprost—Pain—Etoposide—lung cancer	0.000511	0.0013	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000508	0.00429	CbGpPWpGaD
Latanoprost—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000506	0.00129	CcSEcCtD
Latanoprost—Pain—Paclitaxel—lung cancer	0.000501	0.00128	CcSEcCtD
Latanoprost—Oedema—Docetaxel—lung cancer	0.000496	0.00126	CcSEcCtD
Latanoprost—Pruritus—Gemcitabine—lung cancer	0.000495	0.00126	CcSEcCtD
Latanoprost—Nervous system disorder—Docetaxel—lung cancer	0.000487	0.00124	CcSEcCtD
Latanoprost—Skin disorder—Docetaxel—lung cancer	0.000482	0.00123	CcSEcCtD
Latanoprost—Dizziness—Irinotecan—lung cancer	0.000475	0.00121	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—lung cancer	0.000472	0.0012	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—lung cancer	0.000472	0.0012	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—GIPR—lung cancer	0.000455	0.00385	CbGpPWpGaD
Latanoprost—Mediastinal disorder—Methotrexate—lung cancer	0.000454	0.00116	CcSEcCtD
Latanoprost—Rash—Irinotecan—lung cancer	0.000453	0.00115	CcSEcCtD
Latanoprost—Dermatitis—Irinotecan—lung cancer	0.000452	0.00115	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000452	0.00115	CcSEcCtD
Latanoprost—Headache—Irinotecan—lung cancer	0.00045	0.00115	CcSEcCtD
Latanoprost—Dyspnoea—Docetaxel—lung cancer	0.000443	0.00113	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—PTHLH—lung cancer	0.000441	0.00373	CbGpPWpGaD
Latanoprost—Rash—Gemcitabine—lung cancer	0.000441	0.00112	CcSEcCtD
Latanoprost—Dermatitis—Gemcitabine—lung cancer	0.000441	0.00112	CcSEcCtD
Latanoprost—Erythema—Methotrexate—lung cancer	0.000438	0.00112	CcSEcCtD
Latanoprost—Headache—Gemcitabine—lung cancer	0.000438	0.00112	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—lung cancer	0.000429	0.00109	CcSEcCtD
Latanoprost—Pain—Docetaxel—lung cancer	0.000424	0.00108	CcSEcCtD
Latanoprost—Back pain—Methotrexate—lung cancer	0.000424	0.00108	CcSEcCtD
Latanoprost—Pruritus—Etoposide—lung cancer	0.000423	0.00108	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—CHRNB4—lung cancer	0.000419	0.00354	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ANXA1—lung cancer	0.000415	0.00351	CbGpPWpGaD
Latanoprost—Pruritus—Paclitaxel—lung cancer	0.000414	0.00106	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000414	0.0035	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GIPR—lung cancer	0.000413	0.00349	CbGpPWpGaD
Latanoprost—Vision blurred—Methotrexate—lung cancer	0.000413	0.00105	CcSEcCtD
Latanoprost—Rash—Cisplatin—lung cancer	0.000411	0.00105	CcSEcCtD
Latanoprost—Dermatitis—Cisplatin—lung cancer	0.000411	0.00105	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—AVP—lung cancer	0.00041	0.00347	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000402	0.0034	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000397	0.00336	CbGpPWpGaD
Latanoprost—Dizziness—Etoposide—lung cancer	0.000395	0.00101	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—APP—lung cancer	0.000393	0.00332	CbGpPWpGaD
Latanoprost—Mediastinal disorder—Doxorubicin—lung cancer	0.000393	0.001	CcSEcCtD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000392	0.00331	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GNG11—lung cancer	0.000391	0.00331	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA5—lung cancer	0.000389	0.00329	CbGpPWpGaD
Latanoprost—Dizziness—Paclitaxel—lung cancer	0.000387	0.000987	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—GRM8—lung cancer	0.000387	0.00327	CbGpPWpGaD
Latanoprost—Erythema—Doxorubicin—lung cancer	0.00038	0.000967	CcSEcCtD
Latanoprost—Rash—Etoposide—lung cancer	0.000377	0.00096	CcSEcCtD
Latanoprost—Dermatitis—Etoposide—lung cancer	0.000376	0.000959	CcSEcCtD
Latanoprost—Headache—Etoposide—lung cancer	0.000374	0.000953	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—lung cancer	0.000373	0.000951	CcSEcCtD
Latanoprost—Chest pain—Methotrexate—lung cancer	0.000373	0.000951	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000371	0.000944	CcSEcCtD
Latanoprost—Rash—Paclitaxel—lung cancer	0.000369	0.000941	CcSEcCtD
Latanoprost—Dermatitis—Paclitaxel—lung cancer	0.000369	0.00094	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—lung cancer	0.000369	0.00094	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—lung cancer	0.000367	0.000936	CcSEcCtD
Latanoprost—Headache—Paclitaxel—lung cancer	0.000367	0.000935	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—GNG11—lung cancer	0.00036	0.00304	CbGpPWpGaD
Latanoprost—Vision blurred—Doxorubicin—lung cancer	0.000358	0.000911	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000352	0.00298	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000352	0.00297	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GRM8—lung cancer	0.000351	0.00297	CbGpPWpGaD
Latanoprost—Pruritus—Docetaxel—lung cancer	0.000351	0.000895	CcSEcCtD
Latanoprost—Nervous system disorder—Methotrexate—lung cancer	0.000351	0.000894	CcSEcCtD
Latanoprost—Skin disorder—Methotrexate—lung cancer	0.000348	0.000885	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.000335	0.00283	CbGpPWpGaD
Latanoprost—Dizziness—Docetaxel—lung cancer	0.000328	0.000836	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000326	0.00083	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000324	0.00274	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000324	0.00274	CbGpPWpGaD
Latanoprost—Arthralgia—Doxorubicin—lung cancer	0.000323	0.000823	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—lung cancer	0.000323	0.000823	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—AXL—lung cancer	0.000322	0.00272	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000321	0.000818	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—lung cancer	0.000319	0.000814	CcSEcCtD
Latanoprost—Dyspnoea—Methotrexate—lung cancer	0.000319	0.000813	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—OXTR—lung cancer	0.000319	0.00269	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GRP—lung cancer	0.000319	0.00269	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA3—lung cancer	0.000317	0.00268	CbGpPWpGaD
Latanoprost—Rash—Docetaxel—lung cancer	0.000313	0.000797	CcSEcCtD
Latanoprost—Dermatitis—Docetaxel—lung cancer	0.000313	0.000797	CcSEcCtD
Latanoprost—Headache—Docetaxel—lung cancer	0.000311	0.000792	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—lung cancer	0.00031	0.000789	CcSEcCtD
Latanoprost—Pain—Methotrexate—lung cancer	0.000306	0.00078	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—AVP—lung cancer	0.000306	0.00259	CbGpPWpGaD
Latanoprost—Nervous system disorder—Doxorubicin—lung cancer	0.000304	0.000774	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—lung cancer	0.000301	0.000767	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—TF—lung cancer	0.000301	0.00254	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GNG11—lung cancer	0.0003	0.00254	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GNG11—lung cancer	0.000298	0.00252	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000297	0.00251	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000297	0.00251	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—OXTR—lung cancer	0.000289	0.00245	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GRP—lung cancer	0.000289	0.00245	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000282	0.000719	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—lung cancer	0.000276	0.000704	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—GNG11—lung cancer	0.000271	0.00229	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—ADCY1—lung cancer	0.00027	0.00228	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADCY1—lung cancer	0.000268	0.00227	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000267	0.00226	CbGpPWpGaD
Latanoprost—Pain—Doxorubicin—lung cancer	0.000265	0.000675	CcSEcCtD
Latanoprost—Pruritus—Methotrexate—lung cancer	0.000253	0.000645	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—COL4A2—lung cancer	0.000251	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PTHLH—lung cancer	0.000249	0.00211	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000249	0.0021	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GIPR—lung cancer	0.000244	0.00206	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADCY1—lung cancer	0.000244	0.00206	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PPP2R1B—lung cancer	0.000237	0.00201	CbGpPWpGaD
Latanoprost—Dizziness—Methotrexate—lung cancer	0.000237	0.000603	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—ANXA1—lung cancer	0.000234	0.00198	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SDC4—lung cancer	0.000228	0.00193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PTHLH—lung cancer	0.000226	0.00191	CbGpPWpGaD
Latanoprost—Rash—Methotrexate—lung cancer	0.000226	0.000575	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—lung cancer	0.000225	0.000574	CcSEcCtD
Latanoprost—Headache—Methotrexate—lung cancer	0.000224	0.000571	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000224	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—DUSP3—lung cancer	0.000223	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—APP—lung cancer	0.000222	0.00188	CbGpPWpGaD
Latanoprost—Pruritus—Doxorubicin—lung cancer	0.000219	0.000558	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—RHEB—lung cancer	0.000219	0.00185	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000214	0.00181	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ANXA1—lung cancer	0.000213	0.0018	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—AVP—lung cancer	0.000209	0.00176	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRM8—lung cancer	0.000208	0.00175	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000206	0.00175	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—lung cancer	0.000205	0.000522	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000204	0.00172	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—POMC—lung cancer	0.000203	0.00172	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000202	0.00171	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—APP—lung cancer	0.000202	0.00171	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SKI—lung cancer	0.000201	0.0017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COL4A3BP—lung cancer	0.000201	0.0017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AZIN2—lung cancer	0.000201	0.0017	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—lung cancer	0.000198	0.00167	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—lung cancer	0.000195	0.000498	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—lung cancer	0.000195	0.000497	CcSEcCtD
Latanoprost—Headache—Doxorubicin—lung cancer	0.000194	0.000494	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000193	0.00163	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000184	0.00155	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000178	0.0015	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000177	0.0015	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PXN—lung cancer	0.000175	0.00148	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AVP—lung cancer	0.000173	0.00146	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKR1C1—lung cancer	0.000171	0.00145	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRP—lung cancer	0.000171	0.00145	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—OXTR—lung cancer	0.000171	0.00145	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ATP5H—lung cancer	0.000171	0.00144	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000164	0.00138	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000161	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GNG11—lung cancer	0.00016	0.00135	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000159	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—lung cancer	0.000157	0.00133	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AVP—lung cancer	0.000157	0.00133	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000157	0.00132	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFC—lung cancer	0.000152	0.00129	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLBD1—lung cancer	0.000152	0.00129	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000149	0.00126	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000145	0.00123	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000145	0.00123	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADCY1—lung cancer	0.000144	0.00122	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PPP2R1B—lung cancer	0.00014	0.00119	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMARCA4—lung cancer	0.00014	0.00119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD17B10—lung cancer	0.000139	0.00118	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HSPB1—lung cancer	0.000135	0.00114	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000135	0.00114	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TF—lung cancer	0.000135	0.00114	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTHLH—lung cancer	0.000134	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CKB—lung cancer	0.000129	0.00109	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—lung cancer	0.000126	0.00107	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ANXA1—lung cancer	0.000126	0.00106	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MDM2—lung cancer	0.000125	0.00105	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000124	0.00105	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FLT1—lung cancer	0.000122	0.00103	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM2—lung cancer	0.000122	0.00103	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CNDP2—lung cancer	0.000122	0.00103	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—lung cancer	0.000121	0.00102	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH3—lung cancer	0.000119	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APP—lung cancer	0.000119	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF9—lung cancer	0.000118	0.001	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTMR3—lung cancer	0.000118	0.001	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PGAM1—lung cancer	0.000115	0.000974	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—POMC—lung cancer	0.000115	0.000971	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000114	0.000966	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BRAF—lung cancer	0.000114	0.000964	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUNB—lung cancer	0.000113	0.000954	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000111	0.000942	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2A7—lung cancer	0.00011	0.000929	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—lung cancer	0.00011	0.000926	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SDC4—lung cancer	0.000108	0.000909	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—lung cancer	0.000106	0.000897	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—POMC—lung cancer	0.000104	0.000882	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STK11—lung cancer	0.000103	0.000867	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6R—lung cancer	0.000102	0.00086	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FOXO3—lung cancer	9.9e-05	0.000836	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RRM1—lung cancer	9.8e-05	0.000828	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA3—lung cancer	9.8e-05	0.000828	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAP2K1—lung cancer	9.7e-05	0.00082	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—lung cancer	9.63e-05	0.000814	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MDM2—lung cancer	9.56e-05	0.000808	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—RAF1—lung cancer	9.52e-05	0.000805	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—AVP—lung cancer	9.34e-05	0.00079	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AVP—lung cancer	9.27e-05	0.000784	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—lung cancer	9.25e-05	0.000782	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—B4GALT5—lung cancer	9.21e-05	0.000779	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	9.05e-05	0.000765	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA4—lung cancer	8.96e-05	0.000757	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1R—lung cancer	8.93e-05	0.000754	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—lung cancer	8.89e-05	0.000751	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HES1—lung cancer	8.77e-05	0.000741	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA2—lung cancer	8.73e-05	0.000738	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RAF1—lung cancer	8.6e-05	0.000727	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—lung cancer	8.49e-05	0.000718	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA1—lung cancer	8.43e-05	0.000712	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—lung cancer	8.4e-05	0.00071	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCC3—lung cancer	8.33e-05	0.000704	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—lung cancer	8.07e-05	0.000682	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKR1C1—lung cancer	8.07e-05	0.000682	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB3—lung cancer	8.02e-05	0.000678	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UGT1A1—lung cancer	7.83e-05	0.000662	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—lung cancer	7.71e-05	0.000652	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—lung cancer	7.68e-05	0.000649	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GNG11—lung cancer	7.55e-05	0.000638	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR1—lung cancer	7.46e-05	0.000631	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—lung cancer	7.35e-05	0.000621	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOA—lung cancer	7.19e-05	0.000608	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	7.15e-05	0.000604	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA1—lung cancer	7.09e-05	0.000599	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—lung cancer	7.03e-05	0.000594	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA3—lung cancer	6.98e-05	0.00059	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	6.84e-05	0.000578	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADCY1—lung cancer	6.79e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG2—lung cancer	6.79e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO2—lung cancer	6.66e-05	0.000563	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPGDS—lung cancer	6.66e-05	0.000563	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPP2R1B—lung cancer	6.62e-05	0.000559	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—lung cancer	6.47e-05	0.000547	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—lung cancer	6.47e-05	0.000547	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KIT—lung cancer	6.47e-05	0.000547	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—NRAS—lung cancer	6.47e-05	0.000547	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—lung cancer	6.46e-05	0.000546	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGF—lung cancer	6.4e-05	0.000541	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2A6—lung cancer	6.39e-05	0.00054	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCLC—lung cancer	6.39e-05	0.00054	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK3—lung cancer	6.2e-05	0.000524	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—POMC—lung cancer	6.16e-05	0.000521	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BRAF—lung cancer	6.08e-05	0.000514	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO1—lung cancer	6.05e-05	0.000512	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.05e-05	0.000511	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6R—lung cancer	6.01e-05	0.000508	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREBBP—lung cancer	6e-05	0.000507	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—lung cancer	5.9e-05	0.000499	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAP2K1—lung cancer	5.73e-05	0.000484	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—lung cancer	5.69e-05	0.000481	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	5.66e-05	0.000479	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—lung cancer	5.64e-05	0.000476	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—lung cancer	5.57e-05	0.000471	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2E1—lung cancer	5.43e-05	0.000459	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NQO1—lung cancer	5.37e-05	0.000454	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HRAS—lung cancer	5.24e-05	0.000443	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	5.12e-05	0.000433	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—lung cancer	5.12e-05	0.000433	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDM2—lung cancer	5.1e-05	0.000431	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAF1—lung cancer	5.08e-05	0.000429	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—lung cancer	5.03e-05	0.000425	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MTOR—lung cancer	4.96e-05	0.000419	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—lung cancer	4.96e-05	0.000419	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—STK11—lung cancer	4.84e-05	0.000409	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—lung cancer	4.77e-05	0.000403	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRAS—lung cancer	4.74e-05	0.0004	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—lung cancer	4.6e-05	0.000389	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—lung cancer	4.56e-05	0.000386	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—lung cancer	4.56e-05	0.000385	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—lung cancer	4.53e-05	0.000383	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—lung cancer	4.48e-05	0.000378	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—lung cancer	4.44e-05	0.000375	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUN—lung cancer	4.43e-05	0.000375	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAT—lung cancer	4.36e-05	0.000368	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—lung cancer	4.31e-05	0.000364	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—lung cancer	4.3e-05	0.000363	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTEN—lung cancer	4.29e-05	0.000362	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCB1—lung cancer	4.24e-05	0.000358	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—lung cancer	4.18e-05	0.000353	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMS—lung cancer	4.16e-05	0.000352	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—lung cancer	4.11e-05	0.000348	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EP300—lung cancer	4.09e-05	0.000346	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SRC—lung cancer	3.98e-05	0.000336	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A1—lung cancer	3.9e-05	0.00033	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—lung cancer	3.87e-05	0.000327	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ERCC2—lung cancer	3.87e-05	0.000327	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—lung cancer	3.83e-05	0.000324	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NRAS—lung cancer	3.82e-05	0.000323	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK3—lung cancer	3.66e-05	0.00031	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—lung cancer	3.56e-05	0.000301	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—lung cancer	3.48e-05	0.000294	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA1—lung cancer	3.35e-05	0.000283	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—lung cancer	3.29e-05	0.000278	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—lung cancer	3.06e-05	0.000258	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—lung cancer	3.02e-05	0.000256	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—lung cancer	2.93e-05	0.000247	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—POMC—lung cancer	2.91e-05	0.000246	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CREBBP—lung cancer	2.83e-05	0.000239	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRAS—lung cancer	2.8e-05	0.000236	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—lung cancer	2.69e-05	0.000227	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—lung cancer	2.68e-05	0.000226	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—lung cancer	2.65e-05	0.000224	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—lung cancer	2.47e-05	0.000209	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—lung cancer	2.34e-05	0.000198	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—lung cancer	2.32e-05	0.000196	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTEN—lung cancer	2.02e-05	0.000171	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—EP300—lung cancer	1.93e-05	0.000163	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—lung cancer	1.43e-05	0.000121	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—lung cancer	1.17e-05	9.85e-05	CbGpPWpGaD
